Background: Non-invasive therapeutic approaches without negative side-effects are desirable in pain condition treatment where the mobility limiting factor is also there. Repetitive peripheral magnetic stimulation (rPMS) is considered a promising curative method from different perspectives. Because of wide range of therapeutic effects, therapy is mainly indicated in musculoskeletal and neurological disorders. Aim of this study was to investigate pain relief effect and improving of the difficulties in performing Activities of Daily Living (ADL) achived byrPMS among patients with acute and chronic conditions assosiated with musculoskeletal and neurological painful disorders.
INTRODUCTION
The International Association for the Study of Pain describes pain as a subjective unpleasant sensory and emotional experience associated with tissue damage, [1] and it is usually accompanied with limited mobility. Physiological mechanisms producing pain usually include nociceptive irritation, structural brain reorganization and decreased inhibition [1] [2] [3] [4] [5] . Pain is produced as a consequence of a neurological disorder and canbe a direct (neuropathicpain) or an indirect (musculoskeletal) [6] . Direct pain is initiated by a primary lesion or dysfunction in the nervous system and affects the somatosensory [7] . The indirect consequence of neurological disorders is musculoskeletal pain causing both short-and long-term disabilities. The muscoloskeletal pain is further categorized in various types e.g. depending on the persistance -acute and chronic; on the pathophysiological mechanisms -nociceptive and neuropathic; on anatomical localization -sholders, back, head, face etc [8] . Worldwide chronic pain incidence is estimated between 20-25%. Commonly, drug treatment is considered a pain management solution. However, negative side effects such as addiction and temporal character are often overlooked. More than 50% of treated patients describe the drug treatment as inadequate, whereas only few percents of them regain non-painful condition [9, 10] . Therefore, non-invasive solution without negative side-effects is desirable for providing high-quality healthcare to the patients. Basics of repetitive magnetic stimulation have been known  since 19 th century, however, curative effect has been applied in the early 1980´s. The originally known as transcranial magnetic stimulation (TMS) was 'centrally' applicable in neuro-psychiatry. Repetitive peripheral magnetic stimulation´ (rPMS) with curative effect has been proven in many medical branches for pain relief [11] [12] [13] [14] [15] [16] [17] [18] [19] . Comparing to negative side-effects of drug treatment, rPMS is non-invasive therapeutic approach that could have pain relief effect. Both TMS and rPMS share very similar principles of action, where electromagnetic induction is used to generate an electric current across the tissue without a physical contact. An activated coil (plastic enclosed) placed next to the treated region, produces a magnetic field (ones of Tesla), orthogonal to the plane of the coil. The field creates (inducts) electric currents that interact with neuromuscular tissue (in the very same way if currents are applied directly on the treated area). The occurred depolarization of the neuronal cells causes muscle contraction. Therapeutic effects are pain relief, myostimulative, myorelaxative, swelling release effect and circulation improvement [19] . Therefore, the rPMS therapy is indicated in acute (optimally with its high frequency field)and chronic (usually with its low frequency field) painful conditions of the musculoskeletal and neurological disorders. Aim of this study was to evaluate the pain relief effect of rPMS among patients with acute and chronic painful conditions and difficulties to perform ADL accompanying musculoskeletal or neurological disorders.
MATERIALS AND METHODS

Design:
One -site, one-arm, before-after study, conducted in order to investigate pain relief effect of rPMS among patients with painful conditions and difficulties to perform ADL accompanying musculoskeletal or neurological disorders. Participants: 40 patients, aged from 13 to 74 years (n=23 women, n=17 men; mean age 54.6 ± 11.6 years) were comprised in this study. All participants experienced pain and difficulties to perform ADL, led by musculoskeletal or neurological disorders (Participants with heart disorders, any contraindicating implants, seizure neurological or psychiatric conditions etc. were considered disqualified for this study). All participants agreed to voluntarily join the study. A proportional percentage representation (including additional data concerning the ‚before' condition of the patients) is listed in the Patient assessment and therapies were provided by the investigator and research assistants. The device (BTL-6000 Super Inductive System, BTL Industries Ltd.) parameters were stated as follows: magnetic field intensity -up to 2.5T, range of frequency up to 150 Hz and adjustable relative intensity up to 100%. The therapy procedure was followed by manufacturer´s recommendation. The patients with acute pain underwent daily treatments (n=5) with single therapy duration 12 minutes, whereas the patients with acute pain underwent therapy three times per week (n=10) with single therapy duration 10:20 minutes. Therapy frequency was determined by patient´s condition (low frequency field for chronic conditions and high freqeuncy field for patient with acute pain). The intensity was dependent on patient´s subjective perception: the intensity range varied from patient´s lower than up to motor threshold intensity, based on communication between therapist and patient.
Outcome measures and Statistics evaluation:
A primary outcome measure was Pain presence evaluation. A 10-point (0-10; No pain to Worst possible pain) Visual Analog Scale (VAS) for Pain was used to evaluate presence of pain (refer to Appendix 1). The patients were asked to evaluate the level of the pain they experienced right before the first and right after the last treatment (respectively the outcome data were collected right before the first and right after the last treatment). The following question was asked: 'How would you rank the level of your pain?'. Mean improvements in absolute points (Mean ± SD) and levels of improvement (%) were calculated. A secondary outcome measure was evaluation of ability to perform ADL. The evaluation was performed by the means of 24-part (each activity with grade from 0 to 6) Patient Functional Assessment Questionnaire (PFAQ) -refer to Appendix 2. Patients were instructed to circle the level of difficulty per each activity. The score range was varying from 0 to 6, where 0 means that a patient is able to perform activity without any difficulties, whereas 6 means inability to perform such a task. Data were collected right before and right after the last treatment, and at the 3-month follow up. Mean improvements in absolute points (Mean ± SD) and levels of improvement (%) were calculated. A further statistical analysis of 'before' and 'after' conditions was performed by the means of Student's t-test -the purpose was to be proved a statistical significance between the results, signifying a quality to be worthy of attention, importance. Values of p < 0.05 were accepted for statistically significant. RESULTS 40 subjects with acute and chronic painful conditions accompanying musculoskeletal and neurological disorders, which experienced difficulty to perform ADL, ssuccessfully finished a course of treatment with rPMS. During the course of treatments no abnormalities, no side-effects and no aggravation of patient´s condition were observed. The results of VAS for Pain evaluation are summarized in Pujol et al. 1998 has studied the pain relief effect of the direct application of rPMS on the painful limb with a placebo controlled trial among 30 patients in total. The active group experienced 59% pain relief effect while the 14% pain relief was experienced in the control group. However, the mechanism of action remained not clear [11] . Smania et al. 2005 conducted a study researching the pain relief effect of the method among 53 patient with myofascial trigger points randomized as follows: 17 patients were treated by the means of the rPMS , 18 patients received transcutaneous electrical nerve stimulation (TENS) nad the remaining 18 patients were terated with placebo. The rPMS group demonstrated most significant improvement in all studied outcome measures ("neck pain and disability visual analogue scale" (NPDVAS), algometry) [13] . Research on the pain relief effect of the rPMS has been conducted by Lo et al. 2011 among 20 patients randomized in active and control group assuming that the 62.3% pain decrease in the active group (whereas the result in the control group was 6.1%) is resulting from disrupting afferent nerve fibers or activation of spinal and/ or supra spinal inhibitory neurons [15] . Statistical evaluation of the data from the current study proved an immediate pain relief effect from severe level of pain to mild level of pain in post treatment condition of the participants. The 87% pain decrease is resulting in average 41% improvement in performing ADL (from little moderate to little difficulties) and thus affecting the patients quality of life in a positive manner. A persisting improvement to 42% in the ADL scores at 3-month follow up results (vs. pre-treatment condition) is there (see Figure 2. ) signifies for long-lasting therapy effect. Further data analysis by the means of Student's t-test proved a significant pain relief effect resulting in persisting quality of life amelioration among patients with acute and chronic pain associated with musculoskeletal and neurological disorders. This effect is assumed to be led by local circulation improvement.
CONCLUSIONS
The results obtained during the current study provide evidence of effectiveness from rPMS therapy in pain management. The therapy appears effective non-invasive treatment foracute and chronic pain condition and mobility restoration, ameliorating patient quality of life.
